Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 6
1947 2
1948 7
1949 3
1950 1
1951 2
1952 12
1953 7
1954 10
1955 2
1956 7
1957 10
1958 19
1959 9
1960 6
1961 4
1962 8
1963 1
1964 10
1965 8
1966 4
1967 11
1968 17
1969 7
1970 8
1971 8
1972 1
1973 5
1974 15
1975 7
1976 7
1977 16
1978 10
1979 6
1980 12
1981 14
1982 12
1983 9
1984 14
1985 9
1986 7
1987 11
1988 19
1989 24
1990 22
1991 17
1992 22
1993 12
1994 21
1995 28
1996 30
1997 33
1998 31
1999 25
2000 33
2001 38
2002 53
2003 69
2004 52
2005 49
2006 66
2007 78
2008 95
2009 94
2010 105
2011 99
2012 117
2013 119
2014 148
2015 147
2016 169
2017 144
2018 202
2019 214
2020 268
2021 258
2022 263
2023 206
2024 100

Text availability

Article attribute

Article type

Publication date

Search Results

3,481 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H; IBD guidelines eDelphi consensus group; Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB. Lamb CA, et al. Gut. 2019 Dec;68(Suppl 3):s1-s106. doi: 10.1136/gutjnl-2019-318484. Epub 2019 Sep 27. Gut. 2019. PMID: 31562236 Free PMC article. Review.
Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease. ...A systematic review of 88 247 publications and a Delphi consensus process involving 81 multidisciplinary clinicians and patients was undertaken to develop 168 evidence- and exp …
Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease. ...A systematic review of 88 247 public …
A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease.
Seyedian SS, Nokhostin F, Malamir MD. Seyedian SS, et al. J Med Life. 2019 Apr-Jun;12(2):113-122. doi: 10.25122/jml-2018-0075. J Med Life. 2019. PMID: 31406511 Free PMC article. Review.
Ulcerative colitis (UC) and Crohn's disease (CD) are classified as chronic inflammatory bowel diseases (IBD) which have similar symptoms and lead to digestive disorders and inflammation in the digestive system. ...
Ulcerative colitis (UC) and Crohn's disease (CD) are classified as chronic inflammatory bowel diseases (IBD) which have similar sympt …
Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.
Rogler G, Singh A, Kavanaugh A, Rubin DT. Rogler G, et al. Gastroenterology. 2021 Oct;161(4):1118-1132. doi: 10.1053/j.gastro.2021.07.042. Epub 2021 Aug 3. Gastroenterology. 2021. PMID: 34358489 Free PMC article. Review.
It is important to have knowledge of the prevalence, pathophysiology, and clinical presentation of EIMs in order to adapt therapeutic options to cover all aspects of IBD. EIMs can occur in up to 24% of patients with IBD before the onset of intestinal symptoms, and need to …
It is important to have knowledge of the prevalence, pathophysiology, and clinical presentation of EIMs in order to adapt therapeutic …
Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls.
Darnell EP, Mooradian MJ, Baruch EN, Yilmaz M, Reynolds KL. Darnell EP, et al. Curr Oncol Rep. 2020 Mar 21;22(4):39. doi: 10.1007/s11912-020-0897-9. Curr Oncol Rep. 2020. PMID: 32200442 Review.
PURPOSE OF REVIEW: While immune checkpoint inhibitor (ICI) therapy has improved melanoma patient outcomes, it has also resulted in the rise of unique immune-related adverse events (irAEs). ...
PURPOSE OF REVIEW: While immune checkpoint inhibitor (ICI) therapy has improved melanoma patient outcomes, it has also resulted in th …
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.
Nakase H, Uchino M, Shinzaki S, Matsuura M, Matsuoka K, Kobayashi T, Saruta M, Hirai F, Hata K, Hiraoka S, Esaki M, Sugimoto K, Fuji T, Watanabe K, Nakamura S, Inoue N, Itoh T, Naganuma M, Hisamatsu T, Watanabe M, Miwa H, Enomoto N, Shimosegawa T, Koike K. Nakase H, et al. J Gastroenterol. 2021 Jun;56(6):489-526. doi: 10.1007/s00535-021-01784-1. Epub 2021 Apr 22. J Gastroenterol. 2021. PMID: 33885977 Free PMC article. Review.
Inflammatory bowel disease (IBD) is a general term for chronic or remitting/relapsing inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) and Crohn's disease (CD). Since 1950, the number of patients with IBD in Japan has been incre …
Inflammatory bowel disease (IBD) is a general term for chronic or remitting/relapsing inflammatory diseases of the intestinal tract and gene …
Evidence-based clinical practice guidelines for management of colorectal polyps.
Tanaka S, Saitoh Y, Matsuda T, Igarashi M, Matsumoto T, Iwao Y, Suzuki Y, Nozaki R, Sugai T, Oka S, Itabashi M, Sugihara KI, Tsuruta O, Hirata I, Nishida H, Miwa H, Enomoto N, Shimosegawa T, Koike K. Tanaka S, et al. J Gastroenterol. 2021 Apr;56(4):323-335. doi: 10.1007/s00535-021-01776-1. Epub 2021 Mar 12. J Gastroenterol. 2021. PMID: 33710392 Free PMC article. Review.
Recommendation statements for the CQs were limited to items with multiple therapeutic options. Items with established conclusions that had 100% agreement with previous guidelines (background questions) and items with no (or old) evidence that are topics for future research …
Recommendation statements for the CQs were limited to items with multiple therapeutic options. Items with established conclusions tha …
Microscopic colitis: pathophysiology and clinical management.
Miehlke S, Verhaegh B, Tontini GE, Madisch A, Langner C, Münch A. Miehlke S, et al. Lancet Gastroenterol Hepatol. 2019 Apr;4(4):305-314. doi: 10.1016/S2468-1253(19)30048-2. Lancet Gastroenterol Hepatol. 2019. PMID: 30860066 Review.
Two major histological subtypes can be distinguished-collagenous colitis and lymphocytic colitis-but incomplete and variant forms with fewer characteristic features have been reported. ...Further prospective studies are needed to clarify the natural history of micro …
Two major histological subtypes can be distinguished-collagenous colitis and lymphocytic colitis-but incomplete and variant fo …
Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition.
Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, Veres G, Aloi M, Strisciuglio C, Braegger CP, Assa A, Romano C, Hussey S, Stanton M, Pakarinen M, de Ridder L, Katsanos K, Croft N, Navas-López V, Wilson DC, Lawrence S, Russell RK. Turner D, et al. J Pediatr Gastroenterol Nutr. 2018 Aug;67(2):257-291. doi: 10.1097/MPG.0000000000002035. J Pediatr Gastroenterol Nutr. 2018. PMID: 30044357 Free article.
BACKGROUND: The contemporary management of ambulatory ulcerative colitis (UC) continues to be challenging with 20% of children needing a colectomy within childhood years. ...Advice on contemporary therapeutic targets incorporating the use of calprotectin and the rol …
BACKGROUND: The contemporary management of ambulatory ulcerative colitis (UC) continues to be challenging with 20% of children needin …
AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
Green PHR, Paski S, Ko CW, Rubio-Tapia A. Green PHR, et al. Gastroenterology. 2022 Nov;163(5):1461-1469. doi: 10.1053/j.gastro.2022.07.086. Epub 2022 Sep 19. Gastroenterology. 2022. PMID: 36137844 Review.
It will review evaluation of patients with celiac disease who have persistent or recurrent symptoms, differential diagnosis, nutritional support, potential therapeutic options, and surveillance for complications of this condition. ...BEST PRACTICE ADVICE 8: Corticosteroids …
It will review evaluation of patients with celiac disease who have persistent or recurrent symptoms, differential diagnosis, nutritional sup …
Chronic Diarrhea in Adults: Evaluation and Differential Diagnosis.
Burgers K, Lindberg B, Bevis ZJ. Burgers K, et al. Am Fam Physician. 2020 Apr 15;101(8):472-480. Am Fam Physician. 2020. PMID: 32293842 Free article.
Secretory diarrhea can be caused by bile acid malabsorption, microscopic colitis, endocrine disorders, and some postsurgical states. Osmotic diarrhea can present with carbohydrate malabsorption syndromes and laxative abuse. ...Inflammatory diarrhea warrants further evaluat …
Secretory diarrhea can be caused by bile acid malabsorption, microscopic colitis, endocrine disorders, and some postsurgical states. …
3,481 results